217
Views
4
CrossRef citations to date
0
Altmetric
REVIEW

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?

, , , , &
Pages 247-256 | Published online: 29 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lan Wei, Yuanyuan Han & Chao Tu. (2023) Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics. Diabetes, Metabolic Syndrome and Obesity 16, pages 117-128.
Read now

Articles from other publishers (3)

Aadhira Pillai & Darshna Fulmali. (2023) A Narrative Review of New Treatment Options for Diabetic Nephropathy. Cureus.
Crossref
José Jesús Broseta, Marta Roca, Diana Rodríguez-Espinosa, Luis Carlos López-Romero, Aina Gómez-Bori, Elena Cuadrado-Payán, Sergio Bea-Granell, Ramón Devesa-Such, Amparo Soldevila, Pilar Sánchez-Pérez & Julio Hernández-Jaras. (2022) The metabolomic differential plasma profile between dialysates. Pursuing to understand the mechanisms of citrate dialysate clinical benefits. Frontiers in Physiology 13.
Crossref
Huan-Tang Lin, Mei-Ling Cheng, Chi-Jen Lo, Gigin Lin & Fu-Chao Liu. (2022) Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry. Diagnostics 12:11, pages 2626.
Crossref